Intact Vascular, the maker of a device meant to repair tears in the arteries that are typical after an angioplasty, just raised $3 million, according to an SEC filing.
The Pennsylvania company’s product is geared toward the peripheral artery disease set: When arteries narrow or get blocked, patients often require balloon angioplasties to open up the circulatory system and free up blood flow in the limbs. But this procedure causes tears in the arterial walls – and developing a lesion in this situation is no good.
The company’s Tack Endovascular System helps doctors repair these tears while leaving minimal foreign material behind in the arteries. Here’s how it works:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Intact Vascular recently completed a 12-month study of the Tack system in balloon angioplasties (TOBA) among 138 patients in 13 European sites – and results were positive.
“The TOBA experience demonstrates that the long term results from angioplasty can be substantially improved if we repair arterial dissections using this new approach that minimizes vessel trauma and the metal we leave behind,” said co-principal investigator Marc Bosiers, head of the department of vascular surgery at A.Z. St. Blasius Hospital in Belgium. “The Tack supports the dissection and allows the vessel to heal, while preserving future treatment options for patients.”
